tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate

tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate

Intermediate for Olaparib. Olaparib (trade name Lynparza) is a PARP inhibitor for the treatment of germline BRCA mutated (gBRCAm) advanced ovarian cancer that has received three or more prior lines of chemotherapy. Olaparib has been approved by the U.S Food and Drug Administration on December 19, 2014.

Specifications

Product Name:                  tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate

Synonyms:                         N/A

CAS Number:                     414910-15-9

Molecular Weight:            254.3284

Molecular Formula:          C13H22N2O3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(N1CCN(CC1)C(=O)C1CC1)OC(C)(C)C

  • $200.00
  • Ex Tax: $200.00

Available Options